Evidence Synthesis
Masks Investment Sees Significant Improvement in Gross Margin and Close Price The company's gross margin accelerated to 100%, up from -109.82% on a quarterly basis.
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:05
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Masks Investment Sees Significant Improvement in Gross Margin and Close Price The company's gross margin accelerated to 100%, up from -109.82% on a quarterly basis.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | -109.82 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -109.82 % | 81.37 | ▼ |
| REVENUE_GROWTH_YOY | -14.2 % | — | - |
| PRICE_CHANGE_PERCENT | 3.546 % | — | - |
| DAILY_VOLUME | 22 shares | 141 | ▼ |
| CLOSE_PRICE | 148.64 INR | 143.55 | ▲ |